The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
|Articles|October 2, 2012
- Pharmaceutical Technology-10-02-2012
- Volume 36
- Issue 10
Pharmaceutical Technology, October 2012 Issue (PDF)
Combination Drugs - Adding Up the Opportunities in Solid Dosage
Advertisement
Articles in this issue
about 14 years ago
Integration of Less-Formal Risk Assessment Tools into Change Controlabout 14 years ago
Technical Forum: Disposable Chromatographyabout 14 years ago
Uniformity of Dosage Units Using Large Sample Sizesabout 14 years ago
A World without R&Dabout 14 years ago
Supplier Qualificationabout 14 years ago
Determining Potency of Preclinical Dose Formulationsabout 14 years ago
Report from IndiaAdvertisement
Related to this article
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
Advertisement
Advertisement